Lipophilic toxins

Lipophilic toxins are a chemically diverse group of fat-soluble toxic substances with the tendency to dissolve in and accumulate within lipid-rich tissues and cell membranes. Because of their solubility in fats, these compounds readily cross biological membranes, persist in adipose tissue, and bioaccumulate and biomagnify along the food chain, leading to chronic health risks in humans and wildlife. Major representatives of lipophilic toxins include certain marine biotoxins (e.g., okadaic acid, azaspiracids, yessotoxins), persistent organic pollutants (e.g., PCBs, dioxins, DDT), and select mycotoxins. Their toxic effects involve disruption of key cellular and metabolic pathways, often affecting neurological, endocrine, cardiovascular, immune, and metabolic health. Human exposure typically occurs via contaminated seafood or food products, and removal from the body can be very slow due to storage in adipose tissue and resistance to metabolic degradation[2][3][4][5][7].\nThe term "lipophilic toxins" is a *physicochemical descriptor*, *not* a single molecular entity, therapeutic target, or protein. For structured drug discovery or pharmacological contexts, always refer to specific toxin names (e.g., "Okadaic acid" or "Polychlorinated biphenyls") rather than generic class descriptors such as "lipophilic toxins".[1][3][5]

Other names

fat-soluble toxinslipophilic compoundshydrophobic toxinsfat-loving toxins

Not a single mechanism; for specific lipophilic toxins: inhibition of protein phosphatases (e.g., okadaic acid), membrane disruption, mitochondrial dysfunction, receptor antagonism/agonism, etc.